According to Manatt Phelps & Phillips LLP, in an article entitled Mexico’s Healthcare Opportunities: Growing Demand for Private Sector Alternatives, Mexico is today an ideal location for clinical trials conduct, both for biopharmaceutical and medical devices products. The reasons presented are well trained researches (with studies in USA and Europe), medical trial data which can be included in multicentre trials for FDA approval and the high quality academic institutions and hospitals.
To leverage this trend, the Mexican Government is taking measures to speed up trial approval process, with no threatening to public health. With updated legal framework, COFEPRIS, the local regulator, accelerated regulatory approval process, and encouraged multinational biopharmaceutical companies to market their products in Mexico.
Eurotrials is present in Mexico since 2015 – find out more about how we can help you with your project in Mexico in this page.
To read the whole article, click in this link.